Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996758049> ?p ?o ?g. }
- W2996758049 endingPage "25" @default.
- W2996758049 startingPage "13" @default.
- W2996758049 abstract "Purpose of review Exciting translational discoveries in recent years have brought realized promise of immunotherapy for children with high-risk leukemias. This review summarizes the current immunotherapeutic landscape with a focus on key clinical trials for patients with acute lymphoblastic leukemia or acute myeloid leukemia. Recent findings Chemotherapy resistance remains a major barrier to cure in children with high-risk leukemias. Immunotherapy approaches have potential to overcome this resistance given alternative mechanisms of action. Based upon preclinical activity and/or success in adult patients, recent clinical trials have demonstrated safety and efficacy of various mAb, antibody–drug conjugate, bispecific T-cell-engaging antibody, natural killer cell, and chimeric antigen receptor-redirected T-cell immunotherapies for children with acute lymphoblastic leukemia or acute myeloid leukemia. Food and Drug Administration approval of several of these immunotherapies has increased the pediatric leukemia therapeutic portfolio and improved clinical outcomes for previously incurable patients. Summary Several antibody-based or cellular immunotherapy modalities have demonstrated appreciable efficacy in children with relapsed or chemotherapy-refractory leukemia via early-phase clinical trials. Some studies have also identified critical biomarkers of treatment response and resistance that merit further investigation. Continued preclinical and clinical evaluation of novel immunotherapies is imperative to improve cure rates for children with high-risk leukemias." @default.
- W2996758049 created "2019-12-26" @default.
- W2996758049 creator A5049348778 @default.
- W2996758049 creator A5066964026 @default.
- W2996758049 date "2020-02-01" @default.
- W2996758049 modified "2023-09-26" @default.
- W2996758049 title "The future of cellular immunotherapy for childhood leukemia" @default.
- W2996758049 cites W1485169915 @default.
- W2996758049 cites W1488000644 @default.
- W2996758049 cites W1590009046 @default.
- W2996758049 cites W1753684754 @default.
- W2996758049 cites W1964982854 @default.
- W2996758049 cites W1967512987 @default.
- W2996758049 cites W1967517831 @default.
- W2996758049 cites W1967995010 @default.
- W2996758049 cites W1970166604 @default.
- W2996758049 cites W1970610464 @default.
- W2996758049 cites W1976187277 @default.
- W2996758049 cites W1977635228 @default.
- W2996758049 cites W1978649225 @default.
- W2996758049 cites W1981137720 @default.
- W2996758049 cites W1988904395 @default.
- W2996758049 cites W1993732758 @default.
- W2996758049 cites W1994448489 @default.
- W2996758049 cites W1996815863 @default.
- W2996758049 cites W2006436161 @default.
- W2996758049 cites W2009607549 @default.
- W2996758049 cites W2013971016 @default.
- W2996758049 cites W2014659020 @default.
- W2996758049 cites W2017072222 @default.
- W2996758049 cites W2020646453 @default.
- W2996758049 cites W2022881751 @default.
- W2996758049 cites W2025338891 @default.
- W2996758049 cites W2028069487 @default.
- W2996758049 cites W2033857851 @default.
- W2996758049 cites W2047205338 @default.
- W2996758049 cites W2052502668 @default.
- W2996758049 cites W2052605694 @default.
- W2996758049 cites W2075902150 @default.
- W2996758049 cites W2076991609 @default.
- W2996758049 cites W2077248326 @default.
- W2996758049 cites W2091675007 @default.
- W2996758049 cites W2107925822 @default.
- W2996758049 cites W2107943299 @default.
- W2996758049 cites W2107968021 @default.
- W2996758049 cites W2113426218 @default.
- W2996758049 cites W2113802879 @default.
- W2996758049 cites W2118241155 @default.
- W2996758049 cites W2118796952 @default.
- W2996758049 cites W2129676200 @default.
- W2996758049 cites W2129702476 @default.
- W2996758049 cites W2130309988 @default.
- W2996758049 cites W2134853228 @default.
- W2996758049 cites W2136845772 @default.
- W2996758049 cites W2137881702 @default.
- W2996758049 cites W2148594538 @default.
- W2996758049 cites W2151475548 @default.
- W2996758049 cites W2155250860 @default.
- W2996758049 cites W2165635676 @default.
- W2996758049 cites W2165813814 @default.
- W2996758049 cites W2169923083 @default.
- W2996758049 cites W2179454156 @default.
- W2996758049 cites W2211008635 @default.
- W2996758049 cites W2226275287 @default.
- W2996758049 cites W2233225245 @default.
- W2996758049 cites W2258336271 @default.
- W2996758049 cites W2259204994 @default.
- W2996758049 cites W2281010422 @default.
- W2996758049 cites W2284799323 @default.
- W2996758049 cites W2315098267 @default.
- W2996758049 cites W2338392504 @default.
- W2996758049 cites W2340435799 @default.
- W2996758049 cites W2400439118 @default.
- W2996758049 cites W2419639370 @default.
- W2996758049 cites W2461538097 @default.
- W2996758049 cites W2470876555 @default.
- W2996758049 cites W2494984489 @default.
- W2996758049 cites W2496398835 @default.
- W2996758049 cites W2517972616 @default.
- W2996758049 cites W2521461373 @default.
- W2996758049 cites W2529226476 @default.
- W2996758049 cites W2539686048 @default.
- W2996758049 cites W2558503402 @default.
- W2996758049 cites W2606654718 @default.
- W2996758049 cites W2609835530 @default.
- W2996758049 cites W2615844508 @default.
- W2996758049 cites W2619886251 @default.
- W2996758049 cites W2621998980 @default.
- W2996758049 cites W2738977754 @default.
- W2996758049 cites W2743510679 @default.
- W2996758049 cites W2749736858 @default.
- W2996758049 cites W2750168879 @default.
- W2996758049 cites W2761903029 @default.
- W2996758049 cites W2765972717 @default.
- W2996758049 cites W2767440408 @default.
- W2996758049 cites W2768823259 @default.
- W2996758049 cites W2781552270 @default.
- W2996758049 cites W2783779434 @default.